oxprenolol has been researched along with Angor Pectoris in 61 studies
Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We have treated eleven patients with chronic stable angina pectoris with slow-release oxprenolol (160 mg and 320 mg) in a double-blind crossover study and evaluated its efficacy objectively by exercise testing between 180 and 240 min after dosing." | 9.06 | Evaluation of oxprenolol slow release and osmotic release by exercise testing and ambulatory electrocardiographic monitoring in patients with chronic stable angina pectoris. ( Bowles, MJ; Khurmi, NS; O'Hara, MJ; Raftery, EB, 1987) |
| "Oxprenolol and propranolol are noncardioselective beta adrenoreceptor blocking agents known to be equally effective in the management of patients with angina pectoris." | 9.05 | Slow release oxprenolol in angina pectoris: study comparing oxprenolol, once daily, with propranolol, four times daily. ( Olowoyeye, JO; Parker, JO; Thadani, U, 1981) |
| "One hundred and two patients with angina pectoris under treatment with beta-receptor antagonists prescribed on a multi-dose basis were openly switched to treatment with once-daily sustained-release oxprenolol (160 mg per tablet)." | 9.04 | Experience with a sustained-release formulation of oxprenolol in the management of angina pectoris in hospital out-patient departments. ( Forrest, WA, 1978) |
| "1 The effects of atenolol (50 mg and 100 mg) and oxprenolol (80 mg) on respiratory function were studied in ten patients with angina pectoris or hypertension complicated by chronic airways obstruction." | 9.04 | Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction. ( Chatterjee, SS; Croxson, RS; Cruickshank, JM; Perks, WH, 1978) |
| "A random single-blind study of oxprenolol against perhexiline has been undertaken in angina pectoris." | 9.04 | Comparative trial of perhexiline maleate and oxprenolol in patients with angina pectoris. ( Pilcher, J, 1978) |
| "In a double-blind, crossover, randomized study, the therapeutic effectiveness of a single daily dose of slow-release oxprenolol (160 mg/day) was compared with a conventional dosage schedule of propranolol (40 mg three times daily) in eighteen patients with uncomplicated, stable exercise-induced angina pectoris." | 9.04 | Comparison of clinical effects of propranolol (Inderal) with once daily slow-release oxprenolol (Slow Trasicor) in angina pectoris. ( de Feijter, PJ; Majid, PA; Roos, JP; van der Wall, EE; Wardeh, R, 1979) |
| "Nifedipine-induced gingival hypertrophy is a rare side effect reported by the producers of this drug but, surely, not well known in all its aspects." | 7.68 | [Nifedipine and gingival hypertrophy]. ( Borgia, MC; Calpicchio, A; De Paola, G; Di Folco, G, 1991) |
| "We have treated eleven patients with chronic stable angina pectoris with slow-release oxprenolol (160 mg and 320 mg) in a double-blind crossover study and evaluated its efficacy objectively by exercise testing between 180 and 240 min after dosing." | 5.06 | Evaluation of oxprenolol slow release and osmotic release by exercise testing and ambulatory electrocardiographic monitoring in patients with chronic stable angina pectoris. ( Bowles, MJ; Khurmi, NS; O'Hara, MJ; Raftery, EB, 1987) |
| "Oxprenolol and propranolol are noncardioselective beta adrenoreceptor blocking agents known to be equally effective in the management of patients with angina pectoris." | 5.05 | Slow release oxprenolol in angina pectoris: study comparing oxprenolol, once daily, with propranolol, four times daily. ( Olowoyeye, JO; Parker, JO; Thadani, U, 1981) |
| "One hundred and two patients with angina pectoris under treatment with beta-receptor antagonists prescribed on a multi-dose basis were openly switched to treatment with once-daily sustained-release oxprenolol (160 mg per tablet)." | 5.04 | Experience with a sustained-release formulation of oxprenolol in the management of angina pectoris in hospital out-patient departments. ( Forrest, WA, 1978) |
| "1 The effects of atenolol (50 mg and 100 mg) and oxprenolol (80 mg) on respiratory function were studied in ten patients with angina pectoris or hypertension complicated by chronic airways obstruction." | 5.04 | Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction. ( Chatterjee, SS; Croxson, RS; Cruickshank, JM; Perks, WH, 1978) |
| "A random single-blind study of oxprenolol against perhexiline has been undertaken in angina pectoris." | 5.04 | Comparative trial of perhexiline maleate and oxprenolol in patients with angina pectoris. ( Pilcher, J, 1978) |
| "In a double-blind, crossover, randomized study, the therapeutic effectiveness of a single daily dose of slow-release oxprenolol (160 mg/day) was compared with a conventional dosage schedule of propranolol (40 mg three times daily) in eighteen patients with uncomplicated, stable exercise-induced angina pectoris." | 5.04 | Comparison of clinical effects of propranolol (Inderal) with once daily slow-release oxprenolol (Slow Trasicor) in angina pectoris. ( de Feijter, PJ; Majid, PA; Roos, JP; van der Wall, EE; Wardeh, R, 1979) |
| "The symptomatic, electrocardiographic, and circulatory effects of intravenous and oral preparations of propranolol, oxprenolol, and practolol were compared in 16 patients with uncomplicated angina pectoris precipitated by exertion." | 5.04 | Comparison of adrenergic beta-receptor antagonists in angina pectoris. ( Majid, PA; Meeran, MK; Sharma, B; Taylor, SH; Thadani, U; Whitaker, W, 1973) |
| "Nifedipine-induced gingival hypertrophy is a rare side effect reported by the producers of this drug but, surely, not well known in all its aspects." | 3.68 | [Nifedipine and gingival hypertrophy]. ( Borgia, MC; Calpicchio, A; De Paola, G; Di Folco, G, 1991) |
| " Acute dose-response studies showed that all five drugs improved exercise tolerance and reduced ST-segment depression, heart rate and blood pressure by a similar degree in comparison with a placebo (P less than 0." | 2.65 | Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris. ( Davidson, C; Singleton, W; Taylor, SH; Thadani, U, 1979) |
| "Oxprenolol is a potent noncardioselective beta-adrenoceptor blocking drug with partial agonist activity of proved efficacy and high tolerability in patients at risk of various cardiovascular disease syndromes." | 2.36 | Oxprenolol in clinical practice. ( Taylor, SH, 1983) |
| "The association of AILD and myelofibrosis has been rarely encountered and is hereby discussed." | 1.27 | Severe pancytopenia due to marked marrow fibrosis associated with angioimmunoblastic lymphadenopathy. ( Ben Arieh, Y; Brenner, B; Green, J; Nagler, A; Rosenbaum, H; Tatarsky, I, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 59 (96.72) | 18.7374 |
| 1990's | 2 (3.28) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thadani, U | 6 |
| Davidson, C | 2 |
| Singleton, W | 2 |
| Taylor, SH | 6 |
| Jones, GR | 1 |
| Mir, MA | 1 |
| Weber, JC | 1 |
| Frishman, WH | 1 |
| Furberg, CD | 1 |
| Friedewald, WT | 1 |
| Duman, VL | 1 |
| Rozhdestvenskaia, ED | 1 |
| Oranskiĭ, IE | 1 |
| Giec, L | 1 |
| Trusz-Gluza, M | 1 |
| Hübner, D | 1 |
| Olwiński, M | 1 |
| Shanks, RG | 1 |
| Hausen, T | 1 |
| Jenkins, RM | 1 |
| Nagle, RE | 1 |
| Langbehn, A | 1 |
| Beurich, HW | 1 |
| Sheikhzadeh, A | 1 |
| Machtey, I | 1 |
| Olowoyeye, JO | 1 |
| Parker, JO | 1 |
| Antalóczy, Z | 2 |
| Strommer, M | 1 |
| Regös, L | 1 |
| Talbot, S | 1 |
| Zilcher, H | 1 |
| Glogar, D | 1 |
| Hudson, WA | 1 |
| Finnis, WA | 1 |
| Young, DW | 1 |
| Cottam, J | 1 |
| Hoult, JG | 1 |
| Forrest, WA | 3 |
| Sowton, E | 1 |
| Das Gupta, DS | 1 |
| Baker, I | 1 |
| Frisch, P | 1 |
| Goldstraw, PW | 1 |
| Watt, SJ | 1 |
| Perks, WH | 1 |
| Chatterjee, SS | 1 |
| Croxson, RS | 1 |
| Cruickshank, JM | 1 |
| Scardi, S | 2 |
| Borgioni, L | 2 |
| Alberti, E | 1 |
| Palmieri, M | 1 |
| Passarelli, A | 1 |
| Ruggeri, G | 1 |
| Zappalá, A | 1 |
| Baroni, F | 1 |
| Camerini, F | 2 |
| Pilcher, J | 1 |
| Majid, PA | 2 |
| de Feijter, PJ | 1 |
| Wardeh, R | 1 |
| van der Wall, EE | 1 |
| Roos, JP | 1 |
| Short, D | 1 |
| Contino, A | 1 |
| Tormo Alfonso, V | 1 |
| Velasco Rami, JA | 1 |
| Serra Sister, E | 1 |
| Mora Marti, F | 1 |
| Medugno, G | 1 |
| Riavez, R | 1 |
| Tremblay, G | 1 |
| Biron, P | 1 |
| Proulx, A | 1 |
| Muiesan, G | 1 |
| Valori, C | 1 |
| Rivier, JL | 1 |
| Monti, M | 1 |
| Mazzoni, S | 1 |
| Reymond, C | 1 |
| Jaggi, CP | 1 |
| Jaeger, M | 1 |
| Watt, M | 1 |
| Piatak, OA | 1 |
| Yanovskii, GV | 1 |
| Lizogub, VG | 1 |
| Borgia, MC | 1 |
| De Paola, G | 1 |
| Di Folco, G | 1 |
| Calpicchio, A | 1 |
| Losonczy, I | 1 |
| Fülep, I | 1 |
| Kovács, L | 1 |
| Bowles, MJ | 1 |
| Khurmi, NS | 1 |
| O'Hara, MJ | 1 |
| Raftery, EB | 1 |
| Brenner, B | 1 |
| Green, J | 1 |
| Rosenbaum, H | 1 |
| Ben Arieh, Y | 1 |
| Nagler, A | 1 |
| Tatarsky, I | 1 |
| Thompson, MK | 1 |
| Gross, F | 1 |
| Sharma, B | 1 |
| Meeran, MK | 1 |
| Whitaker, W | 1 |
| Lawrence, T | 1 |
| Frankl, WS | 1 |
| de Mey, D | 1 |
| Offerhaus, L | 1 |
| Prichard, BN | 1 |
| Mithal, A | 1 |
| Judge, TG | 1 |
| Ryan, FP | 1 |
| Bakst, A | 2 |
| Lewis, BS | 2 |
| Gotsman, MS | 2 |
| Sandler, G | 1 |
| Pistevos, A | 1 |
| Murakami, M | 1 |
| Murakami, E | 1 |
| Takekoshi, J | 1 |
| Hayase, S | 1 |
| Shintani, H | 1 |
| Lecerof, H | 1 |
| Malmborg, RO | 1 |
| Shah, SJ | 1 |
| Billimoria, AR | 1 |
| Anand, MP | 1 |
| Haveliwala, HK | 1 |
| Vibhakar, BB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Heart Rate Lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease[NCT01365286] | Phase 4 | 40 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for oxprenolol and Angor Pectoris
| Article | Year |
|---|---|
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans | 1984 |
Oxprenolol in clinical practice.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Coronary Disease; Heart Rate; Humans; Hyperte | 1983 |
Beta-blockade withdrawal.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Clinical Trials as Topic; Humans; Myocardial Infarctio | 1975 |
[Therapy and differential therapy with beta sympathicolytic drugs].
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Arrhythmias, Cardiac; Cardiomyopathy, Hype | 1975 |
Beta-adrenergic receptor blocking drugs.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Aortic Aneurysm; Aortic Valve; Arrhythmias | 1973 |
[Clinical application of beta-blockaders].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Anxiety Diso | 1973 |
Beta-adrenergic receptor blocking drugs in angina pectoris.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Blood Pressure; Dose-Response Relationship | 1974 |
Vasodilators..
Topics: Adrenergic alpha-Antagonists; Aminophylline; Angina Pectoris; Bradycardia; Bronchial Diseases; Cereb | 1974 |
24 trials available for oxprenolol and Angor Pectoris
| Article | Year |
|---|---|
Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Blood Pressure; Double-Blind Method; Exercise T | 1980 |
Comparison of antianginal efficacy of one conventional and three long acting beta-adrenoreceptor blocking agents in stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Chronic Disease; Clinical Trials as Topic | 1981 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans | 1984 |
[Slow-Trasicor in the treatment of angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Oxprenolo | 1984 |
The symptomatic and objective effects of nifedipine in combination with beta-blocker therapy in severe angina pectoris.
Topics: Adult; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Hu | 1982 |
Slow release oxprenolol in angina pectoris: study comparing oxprenolol, once daily, with propranolol, four times daily.
Topics: Adult; Angina Pectoris; Blood Pressure; Delayed-Action Preparations; Drug Administration Schedule; F | 1981 |
Beta-blockade withdrawal.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Clinical Trials as Topic; Humans; Myocardial Infarctio | 1975 |
Experience with a sustained-release formulation of oxprenolol in the management of angina pectoris in hospital out-patient departments.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Delayed-Action Preparations; Drug Administra | 1978 |
Comparative effects of beta adrenergic blocking drugs.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Clinical Trials as T | 1975 |
Slow release oxprenolol in angina pectoris [proceedings].
Topics: Angina Pectoris; Clinical Trials as Topic; Delayed-Action Preparations; Humans; Oxprenolol | 1977 |
Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction.
Topics: Adult; Airway Obstruction; Angina Pectoris; Atenolol; Chronic Disease; Clinical Trials as Topic; Dou | 1978 |
[Controlled clinical trial of 5 antianginal treatments].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Drug Combinations; Humans; Isosorbide Dinitr | 1978 |
Comparative trial of perhexiline maleate and oxprenolol in patients with angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Oxprenolo | 1978 |
Comparison of clinical effects of propranolol (Inderal) with once daily slow-release oxprenolol (Slow Trasicor) in angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Delayed-Action Preparations; | 1979 |
Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris.
Topics: Adult; Angina Pectoris; Blood Pressure; Dose-Response Relationship, Drug; Drug Evaluation; Electroca | 1979 |
A double-blind clinical trial in angina pectoris. A comparison between oxprenolol, practolol and placebo.
Topics: Angina Pectoris; Clinical Trials as Topic; Humans; Male; Middle Aged; Oxprenolol; Placebos; Practolo | 1975 |
[Evaluation and comparison of five antianginal treatments by means of a bicycle ergometer exercise test (author's transl)].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; | 1976 |
The influence of adrenoreactive preparations on clinical and haemodynamic parameters in patients with ischaemic heart disease.
Topics: Adult; Angina Pectoris; Coronary Artery Disease; Coronary Disease; Double-Blind Method; Exercise Tes | 1991 |
Evaluation of oxprenolol slow release and osmotic release by exercise testing and ambulatory electrocardiographic monitoring in patients with chronic stable angina pectoris.
Topics: Aged; Angina Pectoris; Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Doubl | 1987 |
Comparison of adrenergic beta-receptor antagonists in angina pectoris.
Topics: Acetanilides; Administration, Oral; Adrenergic beta-Antagonists; Adult; Amino Alcohols; Angina Pecto | 1973 |
Clinical evaluation of oxprenolol in angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Electrocardiography; Female; Heart Function | 1972 |
[Clinical effect of oxprenolol in angina pectoris: comparison with a placebo and propranolol by double blind assay].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Oxprenolo | 1973 |
A total of 254 cases of angina pectoris treated with oxprenolol in hospital practice--a monitored release study.
Topics: Adult; Aged; Amino Alcohols; Angina Pectoris; Clinical Trials as Topic; Female; Humans; Male; Middle | 1972 |
Objective and subjective parameters in angina pectoris (effect of beta-receptor blockade).
Topics: Adult; Aged; Angina Pectoris; Electrocardiography; Female; Humans; Male; Middle Aged; Nitroglycerin; | 1972 |
31 other studies available for oxprenolol and Angor Pectoris
| Article | Year |
|---|---|
Beta-adrenoreceptor antagonists and diplopia.
Topics: Angina Pectoris; Diplopia; Drug Interactions; Humans; Male; Middle Aged; Myasthenia Gravis; Oxprenol | 1982 |
[Use of the beta adrenergic blockader test for evaluation of extracardiac regulation of heart function in patients with coronary pathology of various degrees of severity].
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Coronary Disease; Heart; Humans; Male; Middle A | 1984 |
Studies with long acting propranolol.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Delayed-Action Preparations; Half-Life; Heart Rate; Humans; H | 1984 |
[Withdrawal syndrome following beta blocker therapy (author's transl)].
Topics: Adult; Angina Pectoris; Atenolol; Chlorthalidone; Female; Humans; Hypertension; Middle Aged; Myocard | 1981 |
[The effectiveness of oxprenolol in depot form in stable angina pectoris].
Topics: Aged; Angina Pectoris; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Oxprenolol | 1983 |
Polyarthritis following propranolol.
Topics: Angina Pectoris; Arthritis; Coronary Disease; Female; Humans; Male; Middle Aged; Oxprenolol; Propran | 1981 |
Examinations with oxygen-aparing analgesics in anginous patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Child, Preschool; Dipyrone; Drug Synergis | 1976 |
Angina in hypertensive patients. With particular reference to the negative chronotropic effects of sympatholytic therapy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Bethanidine; Blood Pressure; Debrisoquin; Drug Therapy | 1976 |
[Non arrhythmogenic sudden death as complication of coronary heart disease].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Coronary Artery Bypass; Coronary Disease; Death, | 1979 |
Letter: Oxprenolol and psoriasis-like eruption.
Topics: Adult; Angina Pectoris; Humans; Male; Oxprenolol; Rosacea | 1975 |
Complication of oxprenolol treatment.
Topics: Aged; Angina Pectoris; Duodenal Obstruction; Female; Humans; Ileum; Intestinal Obstruction; Oxprenol | 1977 |
The management of the patient with angina.
Topics: Angina Pectoris; Anticoagulants; Clofibrate; Coronary Artery Bypass; Diazepam; Digoxin; Humans; Isos | 1977 |
[Study of the effects of oxprenolol on pain and on electrocardiographic changes in patients with ischemic heart disease].
Topics: Aged; Angina Pectoris; Arrhythmias, Cardiac; Coronary Disease; Drug Evaluation; Drug Synergism; Elec | 1979 |
[Treatment of angina pectoris with oxprenolol. Its evaluation with ergometric tests].
Topics: Adult; Angina Pectoris; Drug Evaluation; Exercise Test; Heart Rate; Humans; Male; Middle Aged; Oxpre | 1978 |
Quantification pitfalls in comparative studies of antianginal therapies.
Topics: Angina Pectoris; Drug Evaluation; Ethanolamines; Heart Rate; Humans; Lidoflazine; Nitroglycerin; Oxp | 1975 |
[Sympathetic nervous activity and ischemic cardiopathy].
Topics: Aged; Angina Pectoris; Catecholamines; Coronary Disease; Heart Failure; Humans; Male; Middle Aged; M | 1977 |
[The role of reduction of the heart rate in the favorable effect of the beta blockers on myocardial ischemia due to isoprenalin in patients with angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Female; Humans; Isoproterenol; Male; Middle Aged; Ox | 1977 |
Oxprenolol in angina pectoris [proceedings].
Topics: Angina Pectoris; Humans; Male; Oxprenolol | 1976 |
Drug surveillance in general practice: a study of oxprenolol in the treatment of angina.
Topics: Angina Pectoris; Drug Evaluation; Family Practice; Humans; Oxprenolol; Time Factors | 1975 |
The use of Trasicor and hypothiazide in the treatment of hypertension and hypertensive angina pectoris.
Topics: Angina Pectoris; Blood Pressure; Humans; Hypertension; Oxprenolol | 1975 |
[Nifedipine and gingival hypertrophy].
Topics: Angina Pectoris; Drug Therapy, Combination; Gingival Hypertrophy; Humans; Male; Middle Aged; Nifedip | 1991 |
Examination of the cardioprotective effect of Trasicor-80 in primary health care.
Topics: Angina Pectoris; Cardiac Complexes, Premature; Humans; Hypertension; Middle Aged; Oxprenolol | 1986 |
Severe pancytopenia due to marked marrow fibrosis associated with angioimmunoblastic lymphadenopathy.
Topics: Angina Pectoris; Humans; Immunoblastic Lymphadenopathy; Oxprenolol; Pancytopenia; Prednisone; Primar | 1985 |
Effect of oxprenolol on Parkinsonian tremor.
Topics: Aged; Amino Alcohols; Angina Pectoris; Female; Humans; Male; Oxprenolol; Parkinson Disease; Sympatho | 1972 |
[Current drugs. Therapy using -blockaders ( -adrenolytics)].
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Angina Pectoris; Arrhythmias, | 1973 |
[Study of the action of beta-adrenergic blockers in the treatment of angina pectoris].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Cardiac Output; Evaluation Studies as Topic; Female; H | 1972 |
Letter: Adverse reactions to beta-adrenergic blockade.
Topics: Adrenergic beta-Antagonists; Airway Obstruction; Angina Pectoris; Humans; Male; Middle Aged; Oxpreno | 1974 |
Erythroderma due to peritrate and glyceryl trinitrate.
Topics: Angina Pectoris; Dermatitis, Exfoliative; Drug Eruptions; Drug Hypersensitivity; Humans; Male; Middl | 1972 |
Atrial pacing in coronary artery disease.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Coronary Disease; Heart Block; Heart Rate; Huma | 1972 |
Hemodynamic effects of oxprenolol alone and combined with nitroglycerin in patients with ischemic heart disease.
Topics: Administration, Oral; Adult; Angina Pectoris; Blood Pressure; Carbon Dioxide; Cardiac Catheterizatio | 1972 |
Oxoprenolol in angina pectoris.
Topics: Action Potentials; Angina Pectoris; Blood Pressure; Heart; Heart Rate; Humans; Oxprenolol; Physical | 1972 |